Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
367.77
+13.85 (3.91%)
At close: Nov 4, 2026, 4:00 PM EST
367.79
+0.02 (0.01%)
After-hours: Nov 4, 2026, 7:00 PM EST
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.81B in the quarter ending September 30, 2026, with 6.92% growth. This brings the company's total for the last twelve months to $14.59B, up 6.02% year-over-year. In the year 2025, Labcorp Holdings had annual revenue of $13.95B with 7.25% growth. That makes Labcorp Holdings the 1,060th largest company in the world by revenue and 345th in the United States.
Revenue (ttm)
$14.59B
Revenue Growth
+6.02%
P/S Ratio
2.05
Revenue / Employee
$205,556
Employees
71,000
Market Cap
29.86B
Revenue by Segment
- Diagnostics (Dx) 10.88B 77.8%
- Biopharma Laboratory Services (BLS) 3.10B 22.2%
Fiscal year ended Dec 31, 2025 See the full Labcorp Holdings breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.95B | 942.80M | 7.25% |
| Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
| Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
| Dec 31, 2022 | 11.86B | -4.26B | -26.41% |
| Dec 31, 2021 | 16.12B | 2.14B | 15.33% |
| Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
| Dec 31, 2019 | 11.55B | 221.40M | 1.95% |
| Dec 31, 2018 | 11.33B | 1.03B | 9.95% |
| Dec 31, 2017 | 10.31B | 666.20M | 6.91% |
| Dec 31, 2016 | 9.64B | 961.70M | 11.08% |
| Dec 31, 2015 | 8.68B | 2.67B | 44.39% |
| Dec 31, 2014 | 6.01B | 203.30M | 3.50% |
| Dec 31, 2013 | 5.81B | 136.90M | 2.41% |
| Dec 31, 2012 | 5.67B | 129.10M | 2.33% |
| Dec 31, 2011 | 5.54B | 538.40M | 10.76% |
| Dec 31, 2010 | 5.00B | 309.20M | 6.59% |
| Dec 31, 2009 | 4.69B | 189.50M | 4.21% |
| Dec 31, 2008 | 4.51B | 437.00M | 10.74% |
| Dec 31, 2007 | 4.07B | 477.40M | 13.30% |
| Dec 31, 2006 | 3.59B | 263.20M | 7.91% |
| Dec 31, 2005 | 3.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IQVIA Holdings | 17.31B |
| Quest Diagnostics | 11.84B |
| ICON Public Limited Company | 8.23B |
| Agilent Technologies | 7.37B |
| Waters | 5.61B |
| Illumina | 4.54B |
| Mettler-Toledo International | 4.13B |
| Charles River Laboratories International | 4.00B |
LH News
- 11 hours ago - Labcorp to Speak at the UBS Global Healthcare Conference - PRNewsWire
- 11 hours ago - Labcorp price target raised to $400 from $355 at Mizuho - TheFly
- 6 days ago - Labcorp price target raised to $355 from $306 at Deutsche Bank - TheFly
- 6 days ago - Labcorp price target raised to $420 from $380 at UBS - TheFly
- 6 days ago - Labcorp price target raised to $388 from $338 at Morgan Stanley - TheFly
- 6 days ago - Labcorp price target raised to $396 from $361 at Baird - TheFly
- 7 days ago - Labcorp price target raised to $380 from $330 at Barclays - TheFly
- 7 days ago - Labcorp price target raised to $410 from $365 at Leerink - TheFly